Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 458

Results For "CHI"

5488 News Found

Nipah survivors study to advance new vaccines against highly fatal threat
Biotech | March 16, 2022

Nipah survivors study to advance new vaccines against highly fatal threat

CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus


Experts call for capacity building to combat Antimicrobial Resistance
Sustainability | March 16, 2022

Experts call for capacity building to combat Antimicrobial Resistance

The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific


Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
Biotech | March 16, 2022

Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA

The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process


IQVIA launches OCE+ to deliver AI-driven customer engagement
Digitisation | March 16, 2022

IQVIA launches OCE+ to deliver AI-driven customer engagement

OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams


UFDA approves first generic of Symbicort to treat asthma and COPD
Drug Approval | March 16, 2022

UFDA approves first generic of Symbicort to treat asthma and COPD

This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)


Onco aims to make cancer care affordable
Healthcare | March 16, 2022

Onco aims to make cancer care affordable

Onco Care Plus is available at just INR 399 per month, and provides services like free doctor consultation, 15% off on cancer treatment costs, 25% off for diagnostic tests, free nutrition plans, among many more


Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates
Biotech | March 16, 2022

Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates

Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer


SRL Diagnostics and Roche Diagnostics partner to establish an integrated lab
Clinical Trials | March 16, 2022

SRL Diagnostics and Roche Diagnostics partner to establish an integrated lab

Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform


BSV invests in solar power project as part of it sustainability commitment
Sustainability | March 16, 2022

BSV invests in solar power project as part of it sustainability commitment

This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years


Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
News | March 15, 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023